4.8 Article

Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats

Fei Luo et al.

Summary: Through gene editing, researchers successfully established a Tm6sf2(-/-) rat model and found that the loss of the TM6SF2 gene could lead to fatty liver disease and reduced plasma lipid levels. The study revealed that TM6SF2 is predominantly located in the smooth endoplasmic reticulum, promoting lipidation of apolipoprotein B, thereby preventing the occurrence of fatty liver disease.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Pharmacology & Pharmacy

Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress

Seung Yeon Park et al.

Summary: Valdecoxib (VAL) suppresses lipid accumulation in hepatocytes and alleviates hepatic steatosis through the AMPK/SIRT6 pathway. These findings suggest the potential of VAL as a therapeutic agent for non-alcoholic fatty liver disease.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Cell Biology

Cytoplasmic sirtuin 6 translocation mediated by p62 polyubiquitination plays a critical role in cadmium-induced kidney toxicity

Keum-Young So et al.

Summary: The study revealed that polyUb-p62 targeted Sirt6 to autophagosomes, playing a crucial role in Cd-induced cell death and kidney damage.

CELL BIOLOGY AND TOXICOLOGY (2021)

Article Biochemistry & Molecular Biology

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

V. Ratziu et al.

Summary: Aramchol showed potential improvements in liver steatosis and fibrosis in NASH patients, but did not significantly reduce hepatic triglycerides. However, it demonstrated positive effects on liver histology and ALT levels in the clinical trial.

NATURE MEDICINE (2021)

Article Biochemistry & Molecular Biology

ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials

Roberto A. Calle et al.

Summary: The study showed that ACC1/2 inhibitors had a good therapeutic effect in the treatment of non-alcoholic fatty liver disease, significantly reducing liver fat content. Co-administration of PF-05221304 and PF-06865571 can reduce the incidence of adverse events and mitigate the effect of ACC inhibition on serum triglycerides.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

Sven M. Francque et al.

Summary: In a randomized trial, the pan-PPAR agonist Lanifibranor showed significant improvement in histologic features of NASH at a dose of 1200 mg. However, adverse events such as weight gain, anemia, peripheral edema, diarrhea, and nausea were more common with Lanifibranor compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Gastroenterology & Hepatology

Therapeutic pipeline in nonalcoholic steatohepatitis

Raj Vuppalanchi et al.

Summary: The therapeutic pipeline for NASH is expanding with insights into disease pathophysiology, offering potential solutions to resolve steatohepatitis or reverse fibrosis. However, there may be some clinical challenges in the use of these emerging therapies.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Rohit Loomba et al.

Summary: NAFLD and NASH are leading chronic liver diseases worldwide, causing progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. These diseases are associated with hepatic glucose and lipid metabolism, and are influenced by genetic, epigenetic, and environmental factors.
Article Biochemistry & Molecular Biology

Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial

Stephen A. Harrison et al.

Summary: The study demonstrated the efficacy of efruxifermin in treating NASH by significantly reducing HFF levels in patients, with an acceptable safety profile.

NATURE MEDICINE (2021)

Review Physiology

SIRT6, A MAMMALIAN DEACYLASE WITH MULTITASKING ABILITIES

Andrew R. Chang et al.

PHYSIOLOGICAL REVIEWS (2020)

Review Biology

Oxidative stress, nutritional antioxidants and beyond

Qiuping Guo et al.

SCIENCE CHINA-LIFE SCIENCES (2020)

Article Biochemistry & Molecular Biology

SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair

Tianyun Hou et al.

NUCLEIC ACIDS RESEARCH (2020)

Article Biotechnology & Applied Microbiology

Protein acetylation in mitochondria plays critical functions in the pathogenesis of fatty liver disease

Le-tian Zhang et al.

BMC GENOMICS (2020)

Article Multidisciplinary Sciences

Multivalent interactions drive nucleosome binding and efficient chromatin deacetylation by SIRT6

Wallace H. Liu et al.

NATURE COMMUNICATIONS (2020)

Review Gastroenterology & Hepatology

From NASH to HCC: current concepts and future challenges

Quentin M. Anstee et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Biochemistry & Molecular Biology

SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells

Giovanna Sociali et al.

FASEB JOURNAL (2019)

Article Cell Biology

SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPARα

Shoshana Naiman et al.

CELL REPORTS (2019)

Review Gastroenterology & Hepatology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Zobair Younossi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Endocrinology & Metabolism

ACSL5 genotype influence on fatty acid metabolism: a cellular, tissue, and whole-body study

Abishankari Rajkumar et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2018)

Review Biochemistry & Molecular Biology

Mechanisms of NAFLD development and therapeutic strategies

Scott L. Friedman et al.

NATURE MEDICINE (2018)

Review Endocrinology & Metabolism

Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus

Xavier Palomer et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)

Article Cell Biology

p53 cooperates with SIRT6 to regulate cardiolipin de novo biosynthesis

Meiting Li et al.

CELL DEATH & DISEASE (2018)

Article Multidisciplinary Sciences

De novo NAD+ synthesis enhances mitochondrial function and improves health

Elena Katsyuba et al.

NATURE (2018)

Article Gastroenterology & Hepatology

Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease

Karim Gariani et al.

JOURNAL OF HEPATOLOGY (2017)

Article Multidisciplinary Sciences

CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation

Heather J. Wright et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Endocrinology & Metabolism

SIRT6: Novel Mechanisms and Links to Aging and Disease

Luisa Tasselli et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)

Review Endocrinology & Metabolism

Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies

Nishanth E. Sunny et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)

Article Cell Biology

Ceramide Is Metabolized to Acylceramide and Stored in Lipid Droplets

Can E. Senkal et al.

CELL METABOLISM (2017)

Article Biochemistry & Molecular Biology

Identifying the functional contribution of the defatty-acylase activity of SIRT6

Xiaoyu Zhang et al.

Nature Chemical Biology (2016)

Article Multidisciplinary Sciences

SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions

Abhishek Bhardwaj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Nutrition & Dietetics

Acyl-CoA Metabolism and Partitioning

Trisha J. Grevengoed et al.

ANNUAL REVIEW OF NUTRITION, VOL 34 (2014)

Article Multidisciplinary Sciences

The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

Rachel J. Perry et al.

NATURE (2014)

Article Multidisciplinary Sciences

Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion

Ping Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Multidisciplinary Sciences

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

Yang-Lin Liu et al.

NATURE COMMUNICATIONS (2014)

Review Gastroenterology & Hepatology

Mitochondrial Adaptations and Dysfunctions in Nonalcoholic Fatty Liver Disease

Karima Begriche et al.

HEPATOLOGY (2013)

Article Biochemistry & Molecular Biology

Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins

Jessica L. Feldman et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Multidisciplinary Sciences

SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine

Hong Jiang et al.

NATURE (2013)

Article Biochemistry & Molecular Biology

SIRT6 exhibits nucleosome-dependent deacetylase activity

Reuven Gil et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Multidisciplinary Sciences

Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay

Daniel Martinez Molina et al.

SCIENCE (2013)

Article Cell Biology

Multiple Regulatory Layers of SREBP1/2 by SIRT6

Sivan Elhanati et al.

CELL REPORTS (2013)

Article Biochemistry & Molecular Biology

The Deacetylase Sirt6 Activates the Acetyltransferase GCN5 and Suppresses Hepatic Gluconeogenesis

John E. Dominy et al.

MOLECULAR CELL (2012)

Review Endocrinology & Metabolism

Role of ceramides in nonalcoholic fatty liver disease

Mangesh Pagadala et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)

Review Biochemistry & Molecular Biology

Ran-dependent nuclear export mediators: a structural perspective

Thomas Guettler et al.

EMBO JOURNAL (2011)

Article Endocrinology & Metabolism

Palmitate induces insulin resistance without significant intracellular triglyceride accumulation in HepG2 cells

Jin-young Lee et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2010)

Article Multidisciplinary Sciences

SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin

Eriko Michishita et al.

NATURE (2008)

Article Biochemistry & Molecular Biology

Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes

Myoung Sook Han et al.

JOURNAL OF LIPID RESEARCH (2008)

Article Biochemistry & Molecular Biology

Genomic instability and aging-like phenotype in the absence of mammalian SIRT6

R Mostoslavsky et al.

Article Multidisciplinary Sciences

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

LL Listenberger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biotechnology & Applied Microbiology

Correcting mass isotopomer distributions for naturally occurring isotopes

WA van Winden et al.

BIOTECHNOLOGY AND BIOENGINEERING (2002)